Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Olsen, Jeffrey R ^a   Robinson, Clifford G ^a,b   El Naqa, Issam ^a,b   Creach, Kimberly M ^a   Drzymala, Robert E ^a,b   Bloch, Charles ^a,b   Parikh, Parag J ^a,b   Bradley, Jeffrey D ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Cancer; Lung; NSCLC; SBRT; Stereotactic

Indexed keywords

CANCER; LUNG; NSCLC; SBRT; STEREOTACTIC;

DISEASES; MULTIVARIANT ANALYSIS; RADIOLOGY; RADIOTHERAPY; TUMORS;

BIOLOGICAL ORGANS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE CONTROL; DOSE RESPONSE; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; TUMOR BURDEN;

EID: 80255136216     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.01.038     Document Type: Article

References (24)

1. Ettinger DS, Akerley W, Bepler G, et al. NCCN clinical practice guidelines in oncology: Non-small cell lung cancer, version 2, 2010. Available at: http://www.NCCN.org/professionals/physician-gls/PDF/nscl.pdf. Accessed December 20, 2010.
2. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
3. M. Koto, Y. Takai, and Y. Ogawa A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer Radiother Oncol 85 2007 429 434 (Pubitemid 350213143)
4. U. Ricardi, A.R. Filippi, and A. Guarneri Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial Lung Cancer 68 2010 72 77
5. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
6. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
7. P. Baumann, J. Nyman, and I. Lax Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries Acta Oncol 45 2006 787 795 (Pubitemid 44423123)
8. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
9. M. Guckenberger, J. Wulf, and G. Mueller Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: Relevance of 4D dose calculation Int J Radiat Oncol Biol Phys 74 2009 47 54
10. R. Onimaru, M. Fujino, and K. Yamazaki Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 70 2008 374 381
11. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
12. S.M. Yoon, E.K. Choi, and S.W. Lee Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors Acta Oncol 45 2006 1108 1114 (Pubitemid 44808498)
13. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839 (Pubitemid 46630909)
14. J.D. Bradley, I. El Naqa, and R.E. Drzymala Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
15. Y. Xiao, L. Papiez, and R. Paulus Dosimetric evaluation of heterogeneity corrections for RTOG 0236: Stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer Int J Radiat Oncol Biol Phys 73 2009 1235 1242
16. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714 (Pubitemid 47357522)
17. K. Creach, R. Al-Lozi, and I. El-Naqa Dosimetric prediction of chest wall toxicity after lung SBRT Int J Radiat Oncol Biol Phys 78 2010 S181 S182
18. M. Guerrero, and X.A. Li Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy Phys Med Biol 49 2004 4825 4835 (Pubitemid 39433509)
19. K.L. Stephans, T. Djemil, and C.A. Reddy A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: The Cleveland Clinic experience J Thorac Oncol 4 2009 976 982
20. V. Panettieri, B. Wennberg, and G. Gagliardi SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems Phys Med Biol 52 2007 4265 4281 (Pubitemid 47134638)
21. Q.T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809 (Pubitemid 47181385)
22. N.C. Van Der Voort Van Zyp, J.B. Prevost, and M.S. Hoogeman Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome Radiother Oncol 91 2009 296 300
23. Y. Chen, W. Guo, and Y. Lu Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapy Radiother Oncol 88 2008 351 358
24. G.M. Strauss, J.E. Herndon 2nd, and M.A. Maddaus Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol 26 2008 5043 5051